Status:
NOT_YET_RECRUITING
Transcranial Photobiomodulation in Anxiety Disorders
Lead Sponsor:
University of Texas at Austin
Conditions:
Symptoms of Anxiety
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emoti...
Detailed Description
The investigators will conduct two studies: one examining the efficacy of transcranial photobiomodulation as a standalone treatment to alleviate sub-clinical anxiety symptoms and another evaluating th...
Eligibility Criteria
Inclusion
- 18 years of age and older
- State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety)
- Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression)
Exclusion
- STAI score less than 40 or greater than 59
- PHQ-9 score greater than 9
- Medication instability (i.e., medication change within 6 weeks)
- Indicated suicidal ideation
- Currently receiving tPBM treatment
- Current pregnancy
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT07133893
Start Date
September 1 2025
End Date
September 1 2028
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas at Austin
Austin, Texas, United States, 78712